Tempus IPO Soars 9% on Nasdaq Debut, Showcasing Investor Confidence in Health Tech
Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech Tempus, a company focused on genomic testing and data analysis, made a striking debut on Nasdaq last Friday. …